Stock LSB LAKESHORE BIOPHARMA CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases LakeShore Biopharma Co., Ltd

Equities

LSB

KYG9845F1090

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-06-21 EDT 		5-day change 1st Jan Change
0.6 USD +2.56% Intraday chart for LakeShore Biopharma Co., Ltd -14.00% +17.42%
06-10 Lakeshore Biopharma Co., Ltd Announces Executive Changes CI
05-28 YS Biopharma Co., Ltd. will Change its Ticker to LSB from YS CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
LakeShore Biopharma : Resignation of Ms. Chunyuan Wu (Brenda) Form 6 K
PU
LakeShore Biopharma : Departure of Directors Form 6 K
PU
YS Biopharma Announces Name Change to LakeShore Biopharma
PR
YS Biopharma Announces Results of Extraordinary General Meeting
PR
YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer
PR
YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
PR
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024
AQ
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024
PR
YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine
PR
YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024
PR
YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine
PR
YS Biopharma Announces Full Repayment of US$40,000,000 Loan Facility
PR
YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries
PR
YS Biopharma Announces Results of Extraordinary General Meeting held on February 22, 2024
PR
/C O R R E C T I O N -- YS Biopharma Co., Ltd./
PR
YS Biopharma Announces Appointment of New Directors
AQ
YS Biopharma to Hold an Extraordinary General Meeting on February 22, 2024 pursuant to a Shareholder Requisition to Enhance Corporate Governance
PR
YS Biopharma Responds to a Notice of Extraordinary General Meeting of Shareholders of YS Biopharma Co., Ltd.
PR
YS Biopharma Announces US$40 Million Private Placement Financing
PR
YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LSB Stock
  4. News LakeShore Biopharma Co., Ltd
  5. Press Releases